Fidelity Select Biotechnology Portfolio (FBIOX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
19.30
-0.21 (-1.08%)
Mar 13, 2025, 8:02 PM EST
FBIOX Holdings List
As of Dec 31, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 13.66% |
2 | AMGN | Amgen Inc. | 7.26% |
3 | KRYS | Krystal Biotech, Inc. | 6.92% |
4 | VRTX | Vertex Pharmaceuticals Incorporated | 4.49% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 3.98% |
6 | GILD | Gilead Sciences, Inc. | 3.60% |
7 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.60% |
8 | EBR: UCB | UCB SA | 2.50% |
9 | ARGX | argenx SE | 2.49% |
10 | ASND | Ascendis Pharma A/S | 2.14% |
11 | ACLX | Arcellx, Inc. | 1.84% |
12 | CPH: ZEAL | Zealand Pharma A/S | 1.76% |
13 | SRRK | Scholar Rock Holding Corporation | 1.66% |
14 | PCVX | Vaxcyte, Inc. | 1.66% |
15 | INSM | Insmed Incorporated | 1.57% |
16 | BHVN | Biohaven Ltd. | 1.37% |
17 | NTRA | Natera, Inc. | 1.30% |
18 | UTHR | United Therapeutics Corporation | 1.26% |
19 | AVBP | ArriVent BioPharma, Inc. | 1.23% |
20 | IRON | Disc Medicine, Inc. | 1.21% |
21 | CNTA | Centessa Pharmaceuticals plc | 1.17% |
22 | SMMT | Summit Therapeutics Inc. | 1.17% |
23 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.11% |
24 | BPMC | Blueprint Medicines Corporation | 1.01% |
25 | MRUS | Merus N.V. | 0.94% |
26 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.89% |
27 | n/a | Bio Ab2 Holdings Llc Arc | 0.88% |
28 | CADL | Candel Therapeutics, Inc. | 0.80% |
29 | MRNA | Moderna, Inc. | 0.75% |
30 | MNKD | MannKind Corporation | 0.67% |
31 | TGTX | TG Therapeutics, Inc. | 0.65% |
32 | MLTX | MoonLake Immunotherapeutics | 0.65% |
33 | RCUS | Arcus Biosciences, Inc. | 0.61% |
34 | ROIV | Roivant Sciences Ltd. | 0.59% |
35 | CORT | Corcept Therapeutics Incorporated | 0.57% |
36 | VERA | Vera Therapeutics, Inc. | 0.56% |
37 | NRIX | Nurix Therapeutics, Inc. | 0.51% |
38 | XENE | Xenon Pharmaceuticals Inc. | 0.50% |
39 | NUVL | Nuvalent, Inc. | 0.50% |
40 | RVMD | Revolution Medicines, Inc. | 0.49% |
41 | n/a | National Resilience B Pc Pp | 0.48% |
42 | RNA | Avidity Biosciences, Inc. | 0.48% |
43 | n/a | Bridgebio Pharma Inc Pipe | 0.47% |
44 | BNTX | BioNTech SE | 0.47% |
45 | JANX | Janux Therapeutics, Inc. | 0.47% |
46 | VRDN | Viridian Therapeutics, Inc. | 0.45% |
47 | DYN | Dyne Therapeutics, Inc. | 0.44% |
48 | IDYA | IDEAYA Biosciences, Inc. | 0.43% |
49 | VKTX | Viking Therapeutics, Inc. | 0.42% |
50 | APGE | Apogee Therapeutics, Inc. | 0.42% |
51 | PTGX | Protagonist Therapeutics, Inc. | 0.39% |
52 | IMVT | Immunovant, Inc. | 0.38% |
53 | RARE | Ultragenyx Pharmaceutical Inc. | 0.37% |
54 | PRAX | Praxis Precision Medicines, Inc. | 0.36% |
55 | NUVB | Nuvation Bio Inc. | 0.36% |
56 | PTCT | PTC Therapeutics, Inc. | 0.35% |
57 | IONS | Ionis Pharmaceuticals, Inc. | 0.33% |
58 | VRNA | Verona Pharma plc | 0.32% |
59 | RNAC | Cartesian Therapeutics, Inc. | 0.32% |
60 | n/a | Oruka Therapeutics Inc Pipe | 0.32% |
61 | EPA: ALSEN | Sensorion SA | 0.31% |
62 | DAWN | Day One Biopharmaceuticals, Inc. | 0.27% |
63 | SPRY | ARS Pharmaceuticals, Inc. | 0.27% |
64 | KROS | Keros Therapeutics, Inc. | 0.26% |
65 | ELVN | Enliven Therapeutics, Inc. | 0.25% |
66 | APLS | Apellis Pharmaceuticals, Inc. | 0.24% |
67 | NTLA | Intellia Therapeutics, Inc. | 0.24% |
68 | GERN | Geron Corporation | 0.24% |
69 | PRTA | Prothena Corporation plc | 0.24% |
70 | n/a | Bio Ab2 Holdings Llc Adi | 0.24% |
71 | SWX: GALD | Galderma Group AG | 0.24% |
72 | BBIO | BridgeBio Pharma, Inc. | 0.24% |
73 | n/a | Tectonic Therapeutic Inc Pipe | 0.23% |
74 | EXEL | Exelixis, Inc. | 0.22% |
75 | ATYR | aTyr Pharma, Inc. | 0.22% |
76 | n/a | Metsera Inc Ser B Pc Pp | 0.20% |
77 | COGT | Cogent Biosciences, Inc. | 0.20% |
78 | CYTK | Cytokinetics, Incorporated | 0.20% |
79 | DNLI | Denali Therapeutics Inc. | 0.19% |
80 | CRSP | CRISPR Therapeutics AG | 0.19% |
81 | n/a | Summit Therapeutics Inc | 0.19% |
82 | TWST | Twist Bioscience Corporation | 0.18% |
83 | SWTX | SpringWorks Therapeutics, Inc. | 0.18% |
84 | QURE | uniQure N.V. | 0.18% |
85 | LEGN | Legend Biotech Corporation | 0.18% |
86 | n/a | Scorpion Therapeutics B Pc Pp | 0.18% |
87 | n/a | Triveni Bio Inc Series B Pc Pp | 0.18% |
88 | TSHA | Taysha Gene Therapies, Inc. | 0.17% |
89 | UPB | Upstream Bio, Inc. | 0.17% |
90 | GOSS | Gossamer Bio, Inc. | 0.17% |
91 | GPCR | Structure Therapeutics Inc. | 0.17% |
92 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.16% |
93 | SDGR | Schrödinger, Inc. | 0.16% |
94 | ALEC | Alector, Inc. | 0.16% |
95 | PHAT | Phathom Pharmaceuticals, Inc. | 0.16% |
96 | SYRE | Spyre Therapeutics, Inc. | 0.16% |
97 | n/a | Fidelity Cash Central Fund | 0.15% |
98 | AXSM | Axsome Therapeutics, Inc. | 0.14% |
99 | IMCR | Immunocore Holdings plc | 0.13% |
100 | TRDA | Entrada Therapeutics, Inc. | 0.13% |
101 | ATXS | Astria Therapeutics, Inc. | 0.13% |
102 | DSGN | Design Therapeutics, Inc. | 0.12% |
103 | INZY | Inozyme Pharma, Inc. | 0.12% |
104 | TYRA | Tyra Biosciences, Inc. | 0.12% |
105 | ALLO | Allogene Therapeutics, Inc. | 0.12% |
106 | n/a | Cardurion Pharmace Ser B Pc Pp | 0.12% |
107 | n/a | Scorpion Therapeutics Inc Seri | 0.12% |
108 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.11% |
109 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.11% |
110 | NVO | Novo Nordisk A/S | 0.10% |
111 | GLUE | Monte Rosa Therapeutics, Inc. | 0.09% |
112 | NMRA | Neumora Therapeutics, Inc. | 0.09% |
113 | ITCI | Intra-Cellular Therapies, Inc. | 0.09% |
114 | EXAS | Exact Sciences Corporation | 0.08% |
115 | DNTH | Dianthus Therapeutics, Inc. | 0.08% |
116 | CGON | CG Oncology, Inc. | 0.08% |
117 | SEPN | Septerna, Inc. | 0.08% |
118 | RAPP | Rapport Therapeutics, Inc. | 0.07% |
119 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.07% |
120 | BCAX | Bicara Therapeutics Inc. | 0.07% |
121 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.07% |
122 | REPL | Replimune Group, Inc. | 0.07% |
123 | GERNW | Geron Corporation | 0.07% |
124 | IGMS | IGM Biosciences, Inc. | 0.07% |
125 | CRGX | CARGO Therapeutics, Inc. | 0.06% |
126 | IMNM | Immunome, Inc. | 0.06% |
127 | n/a | Crescent Biopharma Inc Pipe | 0.06% |
128 | VTVT | vTv Therapeutics Inc. | 0.06% |
129 | KYMR | Kymera Therapeutics, Inc. | 0.06% |
130 | CLDX | Celldex Therapeutics, Inc. | 0.06% |
131 | n/a | Cartesian Therapeutics ([Wts/Rts]) | 0.05% |
132 | CATX | Perspective Therapeutics, Inc. | 0.05% |
133 | EWTX | Edgewise Therapeutics, Inc. | 0.05% |
134 | THRD | Third Harmonic Bio, Inc. | 0.05% |
135 | AVIR | Atea Pharmaceuticals, Inc. | 0.05% |
136 | HRMY | Harmony Biosciences Holdings, Inc. | 0.05% |
137 | PHVS | Pharvaris N.V. | 0.05% |
138 | SRPT | Sarepta Therapeutics, Inc. | 0.05% |
139 | n/a | Jade Biosciences Inc Pipe | 0.05% |
140 | WVE | Wave Life Sciences Ltd. | 0.05% |
141 | n/a | Candid Therapeutic Ser B Pc Pp | 0.04% |
142 | ZBIO | Zenas BioPharma, Inc. | 0.04% |
143 | STOK | Stoke Therapeutics, Inc. | 0.04% |
144 | ANNX | Annexon, Inc. | 0.04% |
145 | ONC | BeiGene, Ltd. | 0.04% |
146 | TXG | 10x Genomics, Inc. | 0.04% |
147 | BMEA | Biomea Fusion, Inc. | 0.04% |
148 | CAMP | Camp4 Therapeutics Corporation | 0.03% |
149 | RAPT | RAPT Therapeutics, Inc. | 0.03% |
150 | n/a | Korro Bio Inc Pipe | 0.03% |
151 | RCKT | Rocket Pharmaceuticals, Inc. | 0.03% |
152 | RXRX | Recursion Pharmaceuticals, Inc. | 0.02% |
153 | NGNE | Neurogene Inc. | 0.02% |
154 | BEAM | Beam Therapeutics Inc. | 0.02% |
155 | FHTX | Foghorn Therapeutics Inc. | 0.02% |
156 | CTNM | Contineum Therapeutics, Inc. | 0.02% |
157 | GKOS | Glaukos Corporation | 0.02% |
158 | SLNO | Soleno Therapeutics, Inc. | 0.02% |
159 | n/a | Scholar Rock Wt 12/31/25 Pp | 0.02% |
160 | n/a | Elevatebio Llc Ser C Pc Pp | 0.01% |
161 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.01% |
162 | n/a | Warrant on Astria Therapeutics Inc | 0.01% |
163 | NVCR | NovoCure Limited | 0.01% |
164 | SAGE | Sage Therapeutics, Inc. | 0.01% |
165 | ADVM | Adverum Biotechnologies, Inc. | 0.01% |
166 | SWX: IDIA | Idorsia Ltd | 0.01% |
167 | AUTL | Autolus Therapeutics plc | 0.01% |
168 | AURA | Aura Biosciences, Inc. | 0.01% |
169 | n/a | Saliogen Therapeut Ser B Pc Pp | 0.00% |
170 | ABSI | Absci Corporation | 0.00% |
171 | BOLD | Boundless Bio, Inc. | 0.00% |
172 | n/a | Cyclerion Therptcs Inc Pp Pipe | 0.00% |
173 | ORKA | Oruka Therapeutics, Inc. | 0.00% |
174 | n/a | Optinose ([Wts/Rts]) | 0.00% |
175 | n/a | Disc Medicine Inc Cvr Rt | 0.00% |
176 | GRTSQ | Gritstone bio, Inc. | 0.00% |
177 | n/a | Codiak BioSciences Inc Ordinary Shares | 0.00% |
178 | n/a | Aradigm Corp | 0.00% |
179 | n/a | Warrant on Chinook Energy Inc | 0.00% |
180 | n/a | Allena Pharmaceuticals Inc | 0.00% |
181 | n/a | Axcella Health Inc | 0.00% |
182 | n/a | Codiak Biosciences Wt 9/15/27 | 0.00% |
183 | n/a | Medavail Holdings Inc Pipe | 0.00% |
184 | n/a | Afferent Pharma Ser C Pc Pp | 0.00% |
185 | n/a | Aradigm Corp | 0.00% |
186 | n/a | Cash | -0.11% |
187 | n/a | Deferred Tax Liability | -0.17% |
As of Dec 31, 2024